FDA Inspection 1304602 — Therapak Corporation

Therapak Corporation — FEI 3010882984

The FDA completed an inspection of Therapak Corporation on Feb 12, 2026 in Claremont, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 12, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Project Evaluation: Devices
Location
Claremont, CA (United States)

Citations

IDCFRDescription
23212ISO 13485:2016 Clause 8.2.1Feedback process procedures not documented
23252ISO 13485:2016 Clause 8.4Analysis of data not used as input for QMS improvement where necessary

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.